Integra LifeSciences Holdings Corp. (IART)
13.21
-0.32
(-2.37%)
USD |
NASDAQ |
Oct 16, 16:00
13.22
0.00 (0.00%)
After-Hours: 20:00
Integra LifeSciences Holdings Research and Development Expense (Annual) : 34.81M for Dec. 31, 2025
Research and Development Expense (Annual) Chart
Historical Research and Development Expense (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | 34.81M |
| December 31, 2024 | 54.43M |
| December 31, 2023 | 41.94M |
| December 31, 2022 | 41.42M |
| December 31, 2021 | 36.23M |
| December 31, 2020 | 31.17M |
| December 31, 2019 | 33.08M |
| December 31, 2018 | 78.04M |
| December 31, 2017 | 63.46M |
| December 31, 2016 | 57.96M |
| December 31, 2015 | 50.32M |
| December 31, 2014 | 51.10M |
| December 31, 2013 | 51.12M |
| December 31, 2012 | 51.01M |
| December 31, 2011 | 50.78M |
| December 31, 2010 | 48.01M |
| Date | Value |
|---|---|
| December 31, 2009 | 43.68M |
| December 31, 2008 | 35.30M |
| December 31, 2007 | 26.06M |
| December 31, 2006 | 16.93M |
| December 31, 2005 | 11.86M |
| December 31, 2004 | 14.12M |
| December 31, 2003 | 11.46M |
| December 31, 2002 | 8.304M |
| December 31, 2001 | 7.992M |
| December 31, 2000 | 7.524M |
| December 31, 1999 | 8.67M |
| December 31, 1998 | 8.424M |
| December 31, 1997 | 6.406M |
| December 31, 1996 | 6.294M |
| December 31, 1995 | 5.190M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| Penumbra, Inc. | 69.43M |
| Boston Scientific Corp. | 2.052B |
| Globus Medical, Inc. | 146.94M |
| Sight Sciences, Inc. | 14.61M |
| Abbott Laboratories | 2.889B |